Cancer Evolution during Immunotherapy

M. C. Andrews, J. A. Wargo

Research output: Contribution to journalShort SurveyOtherpeer-review

7 Citations (Scopus)

Abstract

Immune checkpoint blockade has revolutionized cancer treatment. In this issue of Cell, insights from a longitudinal multi-omics analysis of the largest yet-reported cohort of melanoma patients reveal how tumor and immunity co-evolve during anti-PD-1 therapy. Immune checkpoint blockade has revolutionized cancer treatment. In this issue of Cell, insights from a longitudinal multi-omics analysis of the largest yet-reported cohort of melanoma patients reveal how tumor and immunity co-evolve during anti-PD-1 therapy.

Original languageEnglish
Pages (from-to)740-742
Number of pages3
JournalCell
Volume171
Issue number4
DOIs
Publication statusPublished - 2 Nov 2017
Externally publishedYes

Cite this